WallStreetZenWallStreetZen

NASDAQ: INDP
Indaptus Therapeutics Inc Stock Ownership - Who owns Indaptus Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Indaptus Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Walt Addison LinscottChief Operating Officer2025-12-2254,421$2.03
$110.47kBuy
Jeffrey A. MecklerCo-Chief Executive Officer2025-12-22216,617$2.03
$439.73kBuy
Michael James NewmanCSO and Director2025-12-2252,204$2.03
$105.97kBuy
Nir SassiChief Financial Officer2025-12-2226,758$2.03
$54.32kBuy

1 of 1

INDP insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when INDP insiders and whales buy or sell their stock.

INDP Shareholders

What type of owners hold Indaptus Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Yun Yao31.51%41,991,000$139.41MInsider
Sino Lion Ventures Ltd29.19%38,895,000$129.13MInsider
Junyi Dai8.44%11,250,000$37.35MInsider
Dexcel Pharma Technologies Ltd3.18%4,234,897$14.06MInsider
Michael James Newman1.10%1,469,430$4.88MInsider
Glen R. Anderson0.98%1,304,318$4.33MInsider
Jeffrey A. Meckler0.17%229,929$763.36kInsider
John W. Kozarich0.11%151,761$503.85kInsider
Walt Addison Linscott0.04%54,426$180.69kInsider
Anthony J. Maddaluna0.04%53,570$177.85kInsider

1 of 3

INDP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
INDP0.00%74.86%Net Buying
IBO0.00%2.75%Net SellingNet Selling
EPRX0.04%0.00%
BLSM0.00%56.05%Net BuyingNet Buying
PHAT0.09%41.16%Net SellingNet Selling
View Top Biotech Stocks

Indaptus Therapeutics Stock Ownership FAQ

Who owns Indaptus Therapeutics?

Indaptus Therapeutics (NASDAQ: INDP) is owned by 0.00% institutional shareholders, 74.86% Indaptus Therapeutics insiders, and 25.14% retail investors. Yun Yao is the largest individual Indaptus Therapeutics shareholder, owning 41.99M shares representing 31.51% of the company. Yun Yao's Indaptus Therapeutics shares are currently valued at $139.41M.

If you're new to stock investing, here's how to buy Indaptus Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.